Loading
Merit Medical Systems Inc Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Floyd David, was filed 06 Aug 2020.
Insider Decl.
489
Thresholds
n/a
Buy Volume
€279,389
3 ops. · all time
Sell Volume
€88M
155 ops. · all time
Who traded when
BuySaleLampropoulos Fred P.7 sales
Lampropoulos Fred P5 sales
Raul Parra Jr.5 sales
Neil W. Peterson3 sales
Peterson Neil3 sales
Brian G. Lloyd2 sales
+6 other insiders
Since the insiders bought
- +48.7%Entry US$44.74 · Close at T+365 US$66.55
- +87.9%Entry US$27.17 · Close at T+365 US$51.06
- +9.6%Entry US$40.79 · Close at T+365 US$44.72
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Merit Medical Systems Inc Buy (bullish), based on 11 analysts. Average price target: US$101.64.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 13,000 of 26,240 companies
51.7
score / 100
Value44
Quality60
FCF yld3.9%
Earn yld2.4%
EV/EBITDA18.9x
ROE9.2%
Gross mgn49%
Net mgn8.5%
Debt/EBITDA2.5x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
US$91.18
Analyst consensus
11 analystsBuy
US$83.00Target US$101.64(+11%)US$123.00
Income statement
RevenueUS$1.5B
Gross profitUS$738.3M49% margin
EBITDAUS$332M22% margin
Net incomeUS$128.5M9.2% margin
Valuation
PER (trailing)37.5x
PER (forward)19.8x
P/Book3.2x
Beta0.51
Balance sheet & cash
Market capUS$5.4B
Total debtUS$821.6M
Free Cash FlowUS$212.5M
Debt / Equity49%
Profitability & ownership
ROE9.2%
ROA4.9%
% insiders2.4%
% institutions107.8%
Last declaration on 9 September 2026
Declarations489 total
8,371 shares0Common Stock, No Par ValueSEC:0001839410-26-000004:0
650 shares0Common Stock, No Par ValueSEC:0001836958-26-000008:0
7,500 shares@ US$90.4480.013% mcap24.2% of flowCommon Stock, No Par ValueSEC:0001926221-26-000008:0
7,500 shares@ US$90.4480.041% mcap26.8% of flowCommonSEC144:0001950047-26-008577
21,449 shares@ US$85.000.034% mcap66.1% of flowCommon Stock, No Par ValueSEC:0001926221-26-000006:0
21,449 shares@ US$85.000.11% mcap73.2% of flowCommonSEC144:0001950047-26-007598
7,500 shares@ US$52.170.0073% mcap35.3% of flowCommon Stock, No Par ValueSEC:0001708144-26-000004:1
13,750 shares@ US$52.170.013% mcap64.7% of flowCommon Stock, No Par ValueSEC:0001708144-26-000004:0
6,409 shares0Common Stock, No Par ValueSEC:0002072266-26-000002:1
6,762 shares0Common Stock, No Par ValueSEC:0002072266-26-000002:2
17,002 shares0Common Stock, No Par ValueSEC:0001926221-26-000004:1
6,409 shares0Common Stock, No Par ValueSEC:0001671772-26-000002:1
17,002 shares0Common Stock, No Par ValueSEC:0001671772-26-000002:2
9,613 shares0Common Stock, No Par ValueSEC:0001742555-26-000002:1
17,002 shares0Common Stock, No Par ValueSEC:0001742555-26-000002:2
6,409 shares0Common Stock, No Par ValueSEC:0001836958-26-000002:1
17,002 shares0Common Stock, No Par ValueSEC:0001836958-26-000002:2
2,018 shares@ US$78.02100.0% of flowCommon Stock, No Par ValueSEC:0002072266-26-000002:3
6,061 shares@ US$78.0212.6% of flowCommon Stock, No Par ValueSEC:0001926221-26-000004:2
5,778 shares@ US$78.022.6% of flowCommon Stock, No Par ValueSEC:0001671772-26-000002:3
5,778 shares@ US$78.022.7% of flowCommon Stock, No Par ValueSEC:0001742555-26-000002:3
6,698 shares@ US$78.02100.0% of flowCommon Stock, No Par ValueSEC:0001836958-26-000002:3
8,203 shares0Common Stock, No Par ValueSEC:0002072266-26-000002:0
7,690 shares0Common Stock, No Par ValueSEC:0001926221-26-000004:0
7,690 shares0Common Stock, No Par ValueSEC:0001836958-26-000002:0
25 of 489 declarations
About Merit Medical Systems Inc
Merit Medical Systems Inc shows 155 sales for EUR 87,929,573, with a median of EUR 332,949, against only 3 purchases for EUR 279,389: purchases are just 2% of open-market trades. The largest sale is by Fred P. Lampropoulos, then President & CEO, with EUR 4,175,309 on September 6, 2019; next come Brian G. Lloyd, Chief Legal Officer, Secretary (EUR 2,904,867 on March 5, 2025) and Raul Parra Jr., CFO and Treasurer (EUR 2,672,325 on November 5, 2024).
The three purchases: EUR 179,244 by Ronald Frost, Chief Operating Officer, on July 30, 2019, EUR 57,858 by Raul Parra Jr. on November 5, 2019 and EUR 42,287 by David Floyd, Director, on August 4, 2020.
Read moreShow less
The record gathers 489 filings from 34 filers between March 3, 2016 and September 9, 2026, with 151 grants and 165 option exercises. The busiest year is 2025, with 81 filings. Fred P. Lampropoulos, Executive Chairman, signed 59 of them. Over the last twelve months: 34 filings, 7 of them sales and none a purchase.
